Amanda Rupert, MD
Gastroenterology · Newark, NJNPI 1821594474
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (51.4%), food and beverage and education — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Medtronic at 54.2% of the total. Reporting peaked in 2024 at $1,035 and has fallen 84.9% since, to $156 in 2025. That places this record below the midpoint for gastroenterology clinicians in NJ, where the typical reported total is $2,298.
Across 30 payments — averaging $53.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$864
- AbbVie$190
- QOL Medical, LLC$125
- Boston Scientific$110
- Johnson & Johnson$67
- Sanofi$40
- plus $198 from 7 others
What the payments were for
- Travel & lodging$81851%
- Food & beverage$70844%
- Education$674%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 7 | $864 |
| AbbVie | 8 | $190 |
| QOL Medical, LLC | 1 | $125 |
| Boston Scientific | 1 | $110 |
| Johnson & Johnson | 1 | $67 |
| Sanofi | 2 | $40 |
| Ironwood Pharmaceuticals, Inc | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Ferring Pharmaceuticals Inc. | 2 | $34 |
| Lilly USA, LLC | 1 | $32 |
| Medline Industries LP | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Bristol Myers Squibb | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EndoFlip$425
- Sucraid$125
- EXALT Model D$110
How this compares
$1,593 in reported general payments places this provider in the 40th percentile of 701 gastroenterology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 16 | $375 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 16 | $255 |
| Famotidine | 13 | $161 |
| Pantoprazole Sodium | 12 | $141 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Newark
- Zamir BrelviNewark$391K
- Jamil ShahNewark$55K
- Vinod RustgiNew Brunswick$431K
- Adam ElfantMount Laurel$385K
- Devjit NayarHoboken$258K
- Lea ChenNew Brunswick$185K
- Alexander PerelmanWest Orange$160K
- Barry KaufmanEgg Harbor Township$157K
- Anish ShethPrinceton$151K
- Ramesh GuptaFair Lawn$143K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.